The Motley Fool
21 Nov 2026, 21:51 UTC · 59m ago
Is Tilray a Buy at Its Record Low, or Is It a Value Trap?
Impact · against what's priced in
The news is a net negative for Tilray as record revenues are revealed to be inorganic, masking a decline in the core cannabis business and a return to operating losses. For the other listed tickers, the market data in the article merely confirms the sharp price declines already reflected in their valuations.
- NVDA+0.00
Already priced in
- The price assumes
The CEO departure and governance crisis: the stock fell 14% to {price} on November 20





